{"id":"W4391257731","doi":"10.51731/cjht.2024.822","title":"Tremelimumab (Imjudo) in Combination With Durvalumab (Imfinzi)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tremelimumab; Durvalumab; Medicine; Internal medicine; Nivolumab; Cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001005363,0.0001830085,0.0002380044,0.0006501817,0.0001380679,0.0006606873,0.0002392868,0.0003406079,0.006178574],"category_scores_gemma":[0.001564427,0.00005690325,0.0003693977,0.000625502,0.0002397897,0.0003619379,0.0002175245,0.0003526803,0.0006600649],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002533758,"about_ca_system_score_gemma":0.002626117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02930291,"about_ca_topic_score_gemma":0.104421,"domain_scores_codex":[0.999693,0.0001060344,0.0000246878,0.00002946734,0.0001125952,0.00003423406],"domain_scores_gemma":[0.9994847,0.0001884591,0.0001452789,0.00001593097,0.0001223309,0.00004337687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001126839,0.00006856751,0.006391473,0.003353288,0.0003973687,0.0002774922,0.00004077784,0.001183497,0.003393083,0.01858041,0.07762723,0.88756],"study_design_scores_gemma":[0.0006396727,0.001309696,0.03898118,0.004095979,0.0008254999,0.001770125,0.0001329912,0.002201143,0.008446559,0.004335783,0.9372165,0.00004501052],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04674661,0.7114031,0.005301736,0.02837244,0.001153988,0.0002432306,0.004502348,0.0001496419,0.2021269],"genre_scores_gemma":[0.4940617,0.4185908,0.0110297,0.008054735,0.0009640693,0.0001466644,0.003281352,0.00003585702,0.0638351],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02930291,"threshold_uncertainty_score":0.05826473,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03239914303394808,"score_gpt":0.2420554489960451,"score_spread":0.209656305962097,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}